NCT03619980View on ClinicalTrials.gov

A Non-Interventional Study to Evaluate Time to Event and Healthcare Resource Utilisation for Prostate Cancer Participants Throughout the Disease Trajectories Until Progression or Death

CompletedOBSERVATIONAL
Enrollment

6,908

Participants

Timeline

Start Date

September 13, 2018

Primary Completion Date

December 10, 2024

Study Completion Date

December 10, 2024

Conditions
Prostate Cancer
Interventions
OTHER

No intervention

Retrospective study to evaluate time to event and healthcare resource utilisation of prostate cancer patients throughout the different disease stages, until progression or death.

Trial Locations (1)

753 09

Site SE46001, Uppsala

All Listed Sponsors
lead

Astellas Pharma Europe Ltd.

INDUSTRY

NCT03619980 - A Non-Interventional Study to Evaluate Time to Event and Healthcare Resource Utilisation for Prostate Cancer Participants Throughout the Disease Trajectories Until Progression or Death | Biotech Hunter | Biotech Hunter